2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Tuesday, June 14, 2016

6:00pm-7:00pm: Clinical, Histologic and Charge Endpoints When Populations with Hepatitis C Recurrence Are Treated with Direct-Acting Antiviral or Interferon Based Therapies.

S. Olson, A. McCann, S. Kumer, T. Schmitt, B. Floyd, R. Taylor, R. Gilroy.

Poster Session D: Viral Hepatitis • Halls C&D

6:00pm-7:00pm: Combined Liver-Kidney Transplantation in Children: Long-Term Follow-Up in 27 Children.

M. Kemper,¹ B. Nashan,² L. Fischer,² F. Brinkert.¹

Poster Session D: Pediatric Liver Transplantation • Halls C&D

6:00pm-7:00pm: Comparison of Efficacy of Different Regimens for Treating Recurrent IgA Nephropathy After Kidney Transplantation.

G. Chen, C. Wang, L. Chen, J. Qiu, C. Wang, J. Fei, S. Deng, J. Li, G. Huang, Q. Fu.

Poster Session D: Poster Session II: Kidney Complications-Other • Halls C&D

6:00pm-7:00pm: Compensating Live Kidney Donors: The Views of United States Voters.

J. Fisher,¹ T. Peters,² R. Gish,³ R. Howard.⁴

Poster Session D: Organizational and Operational Aspects of Transplantation • Halls C&D

6:00pm-7:00pm: Complement Receptor C5aR2 Deletion in Kidney Transplantation in Mice Attenuates Renal Damage.

A. Thorenz,¹ R. Chen,¹ K. Hueper,² B. Hensen,² C. Klemann,³ M. Meier,⁴ A. Klos,⁵ F. Gueler.¹

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection • Halls C&D

6:00pm-7:00pm: Concomitant Proton Pump Inhibitor and Mycophenolate Mofetil Use in Renal Transplant Recipients.

K. Patel,¹ B. Stephany,² J. Barnes,¹ S. Bauer,¹ M. Spinner.¹

Poster Session D: Poster Session II: Kidney Complications-Other • Halls C&D

6:00pm-7:00pm: Contrasting Effects of Tacrolimus and Everolimus on Regulatory T Cell Activation and Mixed Hematopoietic Chimerism Induced by Natural Killer T Cell Stimulation.

S. Miyairi,^1,2 T. Hirai,¹ R. IShii,¹ M. Okumi,¹ Y. Ishii,³ S. Nunoda,² K. Yamazaki,² K. Tanabe.¹

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection • Halls C&D

6:00pm-7:00pm: Conversion from Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma – 2 Year Follow-Up.

R. Hendrickson,¹ W. Andrews,¹ M. Davis,¹ R. Cisneros,¹ R. Fischer,² J. Daniel.²

Poster Session D: Pediatric Liver Transplantation • Halls C&D

6:00pm-7:00pm: Conversion to Belatacept as Rescue Therapy in Kidney Transplant Recipients with Severe Graft Dysfunction.

F. Oldhafer,¹ M. Hiss,² A. Schwarz,² H. Haller,² G. Einecke.²

Poster Session D: Kidney Immunosuppression: Novel Agents • Halls C&D

6:00pm-7:00pm: Conversion to Once-Daily Tacrolimus in Stable Pediatric Liver Transplantation Recipients.

N. Lee, S. Lee, C.-W. Cho, J. Lee, J. Lee, J. Kim, G.-S. Choi, C. Kwon, J.-W. Joh, S.-K. Lee.

Poster Session D: Pediatric Liver Transplantation • Halls C&D